


Somnia Therapeutics Revenue
Biotechnology Research • Cresskill, New Jersey, United States • 1-10 Employees
Somnia Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Somnia Therapeutics
Jian-Qiang Fan
Co-founder, CEO and CSO
Company overview
| Headquarters | Cresskill, New Jersey, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Drug Development, Obstructive Sleep Apnea, Small Molecule Drug |
| Employees | 1-10 |
| Socials |
About Somnia Therapeutics
Somnia is developing oral drugs for treating Obstructive Sleep Apnea (OSA), based on understanding how weak muscle tonicity contributes to the upper airway collapse associated with OSA. Somnia is patient-focused and committed to bringing a safe, convenient, and affordable solution to patients with OSA.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Somnia Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Somnia Therapeutics has never raised funding before.
Somnia Therapeutics Tech Stack
Discover the technologies and tools that power Somnia Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
JavaScript graphics
Analytics
WordPress plugins
Analytics
Tag managers
JavaScript libraries
Frequently asked questions
4.8
40,000 users



